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Summary 
To understand the selective accumulation of memory T helper lymphocytes and of macrophages 
in delayed-type  hypersensitivity (DTH) granulomas, we studied the in situ production of RANTES, 
a chemokine initially characterized on the basis  of its in vitro chemotactic properties for each 
of these cell populations. RANTES gene expression was studied by in situ hybridization in 15 
human lymph nodes presenting typical DTH lesions related to either sarcoidosis or tuberculosis. 
A positive signal was detected in all cases. Labeling was specific for the DTH lesions,  as very 
few if any positive cells were detected in the normal residual lymphoid tissue surrounding them 
or in reactive lymph nodes involved in a B lymphocyte response. R.ANTES gene expression was 
associated with the production of the protein, which was detected by immunochemistry in DTH 
lymph nodes.  The morphological characteristics and distribution  of positive cells  in in  situ 
hybridization and immunochemical experiments indicated that macrophages and endothelial cells, 
two cell populations not previously reported to produce RANTES, contributed to its production 
in DTH reactions. The ability of macrophages and endothelial cells to produce R.ANTES was 
confirmed by in vitro studies with alveolar  macrophages and umbilical vein endothelial cells. 
In view of the chemotactic properties of RANTES for a limited range of cell populations, these 
results suggest that RANTES production in DTH granulomas may play a role in the selective 
accumulation of macrophages and memory T  helper lymphocytes characterizing this type of 
cell-mediated immune reaction, and that macrophages and endothelial cells are involved in this 
production. 
l~ 
ecruitment and in situ accumulation of immune cells 
during  immune reaction is tightly regulated, and  .IL ~,.  an 
the nature of the cell populations homing to immunologi- 
cally active sites varies according to the type of immune re- 
sponse. During delayed-type hypersensitivity (DTH) reactions, 
two cell populations are specifically recruited at the site of 
the lesion:  T  lymphocytes of the helper,  memory subset 
(CD4+CD45RO +) and cells of the monocytic/macrophage 
lineage. Their in situ accumulation leads to the formation 
of a granuloma, which is the histological hallmark of DTH 
reactions. Other cell populations such as CD4+CD45RA + 
T lymphocytes, CD8 + T lymphocytes, and B lymphocytes 
are mostly confined to  the residual lymphoid tissue  sur- 
rounding active granulomas (reviewed in 1-4). This differing 
cell distribution outlines the selectivity of the homing pro- 
cess in the constitution of DTH granulomas. 
A mechanism that may account for the accumulation of 
discrete cell subsets is the local production of specific chemo- 
tactic cytokines, or chemokines (reviewed in 5, 6). One of 
them,  RANTES,  was  shown in vitro to be preferentially 
chemoattractive for human CD4 § memory T lymphocytes 
and monocytes, whereas it displays no significant chemotactic 
property for CD4 + naive T  lymphocytes, CD8 § cytotoxic 
T  lymphocytes, B lymphocytes, or neutrophils  (7). 
The populations of immune cells sensitive to the chemoat- 
tracting properties of RANTES thus appear to be similar 
to those that are detected in DTH granulomas. This led us 
to ask whether in situ production of RANTES could ex- 
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tions. We report that R.ANTES is indeed specificaUy  expressed 
in DTH granulomas, and that in this condition cell popula- 
tions not previously reported to produce R.ANTES contribute 
to its synthesis. 
described (12). The specificity  of the assay was tested with other 
soluble proteins, including other chemokines of both the C-X-C 
(1I.-8, melanocyte growth stimulator), activity) and C-C (macro- 
phage inflammatory  protein [MIP]-lot, MIP-1/~, monocyte chemo- 
tactic protein [MCP]-I) classes, none of  which were shown to cross 
react in the assay. 
Materials and Methods 
Tissues and Cells.  All tissues were processed as previously de- 
scribed (8). They included 15 lymph nodes displaying abundant 
granulomas typical of  DTH reactions, related to sarcoidosis  in eight 
cases and tuberculosis in seven  cases, and 6 lymph nodes exhibiting 
follicular hyperplasia of unknown origin. 
Alveolar cells were obtained by bronchoalveolar lavage (BAL) 
of two healthy human volunteers. Adherent cells were suspended 
at 106 cells/ml in ILPMI 1640 supplemented with 10% AB serum 
and cultured in the presence of IFN-'y (500 U/ml) for 4 d. They 
were then centrifuged at 800 g for 10 rain using a cytospin, air- 
dried for 2 h, fixed in acetone for 5 rain, and stored at  -80~ 
until used. More than 95% of these BAL cells expressed either CD68 
or HLA-DR,  as assessed by immunochemistry and flow cytom- 
etry, respectively. 
Human umbilical  vein endothelial  cells (HUVEC) were extracted 
by collagenase  treatment of  human umbilical veins. They were cul- 
tured (5  x  104 per cm  2) in MCDB 107 medium (Sigma Chem- 
ical Co., St. Louis, MO) supplemented with 10% fetal calf serum, 
90 #g/ml heparin (Sigma  Chemical Co.), and 40/~g/ml endothelial 
cell growth supplements (ECGS; Sigma Chemical Co.). More than 
90% HUVEC were labeled with a polyclonal antifactor VIII anti- 
body (Dakopatts, Glostrup, Denmark). Before  stimulation they were 
washed and cultured during 24 h in flesh medium without heparin 
and ECGS. They were then placed  in fresh medium without heparin 
and ECGS and stimulated or not with TNF-c~ (200 U/m1) and 
IFN-y (200 U/ml). After 24 h, supernatants and cells were recov- 
ered as described above. 
In Situ Hybridization.  In situ hybridization experiments were 
performed on frozen tissue sections  as previously  described (8). The 
RANTES-specific probe  was  constructed  by cloning  a 411-bp 
EcoRI-Apal  fragment of the human RANTES cDNA (for se- 
quence, see reference 9) across the EcoRI-Apal restriction sites of 
the Bluescript plasmid (Stratagene, La Jolla, CA). The antisense 
probe was obtained by linearizing  the resulting plasmid with EcolLl 
and synthesizing a clLNA from the T3 promoter. The sense probe 
was obtained by linearizing the plasmid with ApaI and using the 
T7 promoter. In situ hybridization for IL-13 and IFN-3' was as 
previously  described (10). For each patient, four to eight tissue sec- 
tions were analyzed. 
ImmunohistochemicalAnalysis.  The RANTES mAb (an IgG2a) 
was used at a final dilution of 0.9/~g/ml. As a control, a mAb 
of the same isotype, the F39-20 mAb (a gift from M. A. Petit, 
INSERM U131) (11), was used at the same concentration. CD68 
mAb was from Behring (KiM7; Rueil-Malmaison,  France) and CD3 
mAb was from Becton-Dickinson  (Pont-de-Clay,  France). Immuno- 
histochemical analysis  was performed using an avidin-biotin tech- 
nique according to manufacturer's recommendations (Vectastain 
ABC kit, Vector Laboratories, Inc., Burlingame, CA) except that 
50% (vol/vol) normal human serum was added in the first blocking 
step. 
RANTES ELISA.  RANTES concentrations were measured 
by a sandwich ELISA, the details of  which are to be published else- 
where (Sadick, M., and T. Schall, manuscript  in preparation). Briefly, 
the assay  employs  two anti-RANTES mAbs that recognize  different, 
noncompeting determinants. A standard curve was generated as 
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Results 
Expression of the RANTES Gene in DTH Reactions.  Ex- 
pression of the RANTES gene was studied by in situ hybrid- 
ization in 15 lymph nodes displaying morphological changes 
typical of granulomatous DTH reactions, related to sarcoid- 
osis in eight cases and to tuberculosis in the seven other cases. 
Similar results were obtained for both conditions. 
Positive cells were evidenced in all cases using the R.ANTES 
antisense probe (Fig. 1 A). They were abundant in most cases. 
No positive cells were detected in parallel experiments in which 
the RANTES sense probe was used as a control (Fig.  1 B). 
Cells expressing the RANTES gene were mostly located in- 
side granulomas, and to a lesser extent in the inflammatory 
reaction surrounding granulomas. In contrast, they were ab- 
sent or very rare in the normal residual lymphoid tissue of 
the lymph node. 
Six lymph nodes exhibiting a follicular hyperplasia  were 
tested in parallel.  Cells containing RANTES mRNA were 
completely absent in four cases and exceptionally detected 
(less than two positive cells per tissue section)  in the two 
other cases (data not shown). 
Production of  the RANTES Protein in DTH Reactions,  Cells 
containing RANTES mRNA do not always produce the pro- 
tein (13). We therefore analyzed in DTH reactions produc- 
tion of the R.ANTES protein using a specific mAb.  CeUs 
labeled with the anti-RANTES mAb were detected in 14 
of the 15 DTH lymph nodes. They were mainly located in- 
side granulomas (Fig.  1 C). Scattered cells were also present 
in the perigranulomatous inflammatory  reaction, whereas they 
were either rare  or absent in the normal lymphoid tissue. 
No signal was observed with a control mAb of the same iso- 
type (Fig.  1 D). 
Granulomas were usually diffusely stained in in situ hy- 
bridization and immunohistochemical experiments,  although 
a peripheral pattern of in situ message expression and protein 
detection was seen in few cases. Thus, both approaches gave 
concordant results indicating local and specific production 
of the RANTES chemokine in DTH reactions. 
Characterization of  RANTES-producing Cells in DTH Reac- 
tions.  Characteristics of the pattern of RANTES mRNA 
expression  suggested that most positive cells in granulomas 
belonged to the macrophage rather than to the T  lympho- 
cyte lineage.  Indeed, this pattern was identical to that ob- 
tained with an IL-1B specific probe, a monokine previously 
shown to be strongly expressed by macrophages in DTH reac- 
tions (see reference 14), whereas it was quite different from 
that of INF-3', which was detected in isolated and smaller 
cells corresponding  to  activated T  lymphocytes (14). Im- 
munochemical analysis with the anti-RANTES mAb showed 
that large ceils with processes and epitheloid cells were stained. 
This pattern of labeling was similar to that of CD68 + mac- 
R.ANTES Production in Delayed-type  Hypersensitivity  Granulomas Figure  1.  RANTES  production 
in DTH granulomas.  Production  of 
RANTES was studied  in 15 lymph 
nodes with DTH granulomas. In 
situ hybridization  experiments  were 
performed with an antisense (A) 
or a sense (B) probe specific for 
RANTES gene. Immunochemistry 
was  performed with  an  anti- 
RANTES mAb  (C)  or  with  a 
control mAb (D). Original  magnifi- 
cation: x400in.A and B; x200in 
C and D.  G, DTH granulomas; 
EG, extra-granulomatous  lymphoid 
tissue. 
rophages but clearly different from that of CD3 + T  cells 
(Fig.  2). Although the presence of RANTES-producing T 
lymphocytes cannot be formally  ruled out based on morpho- 
logical criteria, such ceils if present should be much less abun- 
dant than RANTES-producing macrophages. 
In addition to macrophages, endothelial cells also expressed 
the R.ANTES gene.  Indeed, cells whose morphology and 
location was consistent with that of endothelial cells were 
found to contain both RANTES mRNA and protein (Fig. 
3). These RANTES-producing endothelial cells were found 
in the inflammatory reaction surrounding granulomas. 
In  Vitro Production of RANTES  by Macrophages and En- 
dothelial Cells.  Neither macrophages nor endothelial cells 
have  previously been  reported  to  produce  RANTES.  To 
confirm our in vivo findings we tested whether these cell 
populations can synthesize the chemokine in vitro. 
Production of RANTES by BAL macrophages was studied. 
Expression of the RANTES gene was not detected by in situ 
hybridization in freshly isolated ceils. In contrast, >60% of 
cells were labeled with the RANTES antisense probe after 
4 d of culture in the presence of IFN-y (Fig. 4). The super- 
natant of these 4-d cultures contained 770 pg/ml of RANTES. 
HUVEC were also tested for R.ANTES gene expression. 
In the absence of stimulation, HUVEC were not labeled with 
the antisense probe, and their 24-h supernatant contained less 
than 200 pg/ml of R.ANTES. In contrast, more than 50% 
of cells stimulated with TNF-ot and IFN-'y expressed  the 
R.ANTES gene in in situ hybridization experiments, and their 
supernatant contained 2,260 pg/ml of R_ANTES. Therefore, 
both macrophages and endothelial cells can produce RANTES 
upon stimulation. 
Figure  2.  Characteristics  of granulomatous  cells. The morphology  and 
distribution of cell populations  in DTH granulomas  were studied  by im- 
munochemistry. (A) Labeling  of macrophages using a CD68 mAb; (B) 
labeling  ofT lymphocytes  with a CD3 mAb. Original  magnification: x400. 
Discussion 
This study shows that the RANTES gene is strongly ex- 
pressed in lymphoid tissues involved in granulomatous DTH 
reactions. The production of RANTES appears to be specific 
to this kind of immune reaction, as virtually no cell expressed 
the RANTES gene in lymph nodes involved in a humoral 
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R.ANTES by endothelium  in peri- 
granulomatous vessels. Lymph 
nodes with DTH granulomas  were 
analyzed for the presence of cells 
with endothelial  morphology  and 
producing RANTES. In situ hy- 
bridization experiments were per- 
formed with an antisense (A) or a 
sense (B) RANTES probe. Immu- 
nochemistry  was performed  with  an 
anti-RANTES mAb (C) or a con- 
trol mAb (/9). Original magnifi- 
cation: x400  in A and B; x250 in 
C  and  D.  (Arrows)  RANTES- 
producing cells. 
immune response.  The pattern of RANTES production was 
indistinguishable in cases of tuberculosis and sarcoidosis, in- 
dicating that the nature of the immune reaction in process, 
DTH, was more important than the triggering agent itself 
Figure  4.  RANTES  gene  expression  by normal  macrophages.  Human 
macrophages were collected  by BAL and cultured for 4 d in the presence 
of IFN-~/(500 U/ml). Expression of the RANTES gene was then deter- 
mined  by in situ hybridization  with an antisense  (A) or a sense  (B) probe. 
Original magnification: x400. 
for induction of RANTES gene expression.  In vivo expres- 
sion of RANTES gene has been reported in arteriosclerosis 
(15),  indicating that the spectrum of conditions in which 
KANTES is produced in humans is not restricted to DTH 
granulomas. 
The  two  main  partners  of DTH  reactions  are  CD4 + 
memory T  lymphocytes and macrophages, which are both 
known targets for RANTES. This suggests that RANTES 
production plays a critical role in the accumulation of both 
cell populations in DTH granulomas, acting in concert with 
additional chemokines including MCP-1 or inducible pro- 
tein [IP]-10 (16, 17). RANTES does not chemoattract naive 
T  lymphocytes, B lymphocytes, or neutrophils (7),  which 
may explain the paucity of such cells in DTH granulomas. 
Although it displays potent chemoattracting properties for 
eosinophils in vitro (18-20), eosinophils are absent in DTH 
reactions,  suggesting that the in vivo effects of KANTES 
on its potential targets may be restricted by additional factors 
present in the microenvironment such as the relative produc- 
tion of Thl- vs.  Th2-type cytokines. 
R_ANTES was initially characterized as a product of acti- 
vated T lymphocytes (9),  and was subsequently reported to 
be also produced by kidney epithelial cells, platelets, and fibro- 
blasts  (6,  12,  18,  21). We show that macrophages and en- 
dothelial  cells  also  produce  R.ANTES.  Macrophages  are 
thus producers as well as targets of RANTES,  suggesting 
that  their  recruitment  in  DTH  granulomas may be  self- 
perpetuating. Endothelial cells synthesize MCP-1, IL-8, and 
IP-10  (22)  in addition to P_ANTES,  and may thus have a 
dual effect on recruitment of immune cells. By expressing 
adhesion molecules, they may allow binding of circulating 
cells to their surface, and by expressing chemokines, they may 
trigger migration of these cells to the site of the immune 
reaction. The range of adhesion molecules and of chemokines 
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which cell populations will participate in the immune reac- 
tion. In DTH reactions, endothelial cells are not present in 
granulomas  but in the inflammatory reaction  surrounding 
them. From this site, they may selectively recruit circulating 
macrophages  and  CD4 §  memory  T  helper  lymphocytes, 
which will then  migrate  to the granuloma. 
Production of RANTES by macrophages and endothelial 
ceils is itself integrated in a network of cytokine production. 
Synthesis of RANTES is upregulated by IFN-3,, IL-1B, and 
TNF-ot (12, and this work). Interestingly, increased produc- 
tion of IFN-% IL-1B, and TNF-ot is a specific feature of DTH 
granulomas  (14,  23-28).  This  suggests  that  the  self-per- 
petuation of DTH granulomas may result from a cascade of 
cytokine production as follows. Macrophages produce IL-I~ 
and TNF-ot and CD4 + memory Thl-type lymphocytes pro- 
duce IFN-% These three cytokines act in synergy to induce 
production of R.ANTES, which leads to recruitment of ad- 
ditional macrophages and memory T helper cells in the granu- 
loma. This action of IL-1/3, TNF-ot, and IFN-'y on R.ANTES 
production would complete their enhancing effect on adhe- 
sion molecule expression by endothelial cells (29-31).  Such 
a self-renewing loop may shed light  on the mechanism by 
which Th2 cytokines downregulate the formation of DTH 
granulomas.  IL-4 and IL-10 each inhibit production of IL- 
13,  TNF-c~, and IFN-3, (32-36),  and IL-4 directly down- 
regulates  RANTES production  (12). 
This study provides clues to the selective accumulation of 
CD4 § memory T  lymphocytes and of macrophages inside 
DTH granulomas,  an event that may be dependent on the 
in situ production of the RANTES chemokine. The involve- 
ment of macrophages and endothelial cells in this local pro- 
duction  is  also  shown,  thus  widening  the  spectrum  of 
RANTES-producing cells and outlining the role of both cell 
populations  in the constitution  of DTH granulomas. 
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